Media-OutReach Newswire Novel Chinese medicine for constipation developed by HKBU authorised by U.S. FDA for clinical trial
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.